AGP Picks
View all

My Health News Nevada
Provided by AGP

My Health News Nevada: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on My Health News Nevada.

September 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6
7 8 9 10 11 12 13
14 15 16 17 18 19 20
21 22 23 24 25 26 27
28 29 30

October 2026

Mo Tu We Th Fr Sa Su
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31

November 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30

Press releases published on November 5, 2026

Tangram annonce la présentation orale des données précliniques sur le TGM-148, mettant en évidence son mécanisme d’action dépendant du contexte, à l’occasion du congrès annuel 2026 de l’American Society of Hematology (ASH)
Nov. 5, 2026

Tangram annonce la présentation orale des données précliniques sur le TGM-148, mettant en évidence son mécanisme d’action dépendant du contexte, à l’occasion du congrès annuel 2026 de l’American Society of Hematology (ASH)

Indeterminate GlobeNewswire
Vericel Reports Third Quarter 2026 Financial Results and Raises Full-Year Financial Guidance
Nov. 5, 2026

Vericel Reports Third Quarter 2026 Financial Results and Raises Full-Year Financial Guidance

Indeterminate GlobeNewswire
AVITA Medical Announces National Medicare Physician Payment Framework and Simplified Billing Codes for RECELL Procedures in 2027
Nov. 5, 2026

AVITA Medical Announces National Medicare Physician Payment Framework and Simplified Billing Codes for RECELL Procedures in 2027

Indeterminate GlobeNewswire
NorthStrive Biosciences Announces Results from EL-32 Preclinical Combination Study with Semaglutide and Plans for Next Phase of Development
Nov. 5, 2026

NorthStrive Biosciences Announces Results from EL-32 Preclinical Combination Study with Semaglutide and Plans for Next Phase of Development

Indeterminate GlobeNewswire
Cabaletta Bio Reports Third Quarter 2026 Financial Results and Provides Business Update
Nov. 5, 2026

Cabaletta Bio Reports Third Quarter 2026 Financial Results and Provides Business Update

Indeterminate GlobeNewswire
Collegium Reports Third Quarter 2026 Financial Results; Reaffirms 2026 Guidance
Nov. 5, 2026

Collegium Reports Third Quarter 2026 Financial Results; Reaffirms 2026 Guidance

Indeterminate GlobeNewswire
Cronos Group Reports 2026 Third Quarter Results
Nov. 5, 2026

Cronos Group Reports 2026 Third Quarter Results

Indeterminate GlobeNewswire
SAB BIO Reports Q3 2026 Financial Results and Provides Business Highlights
Nov. 5, 2026

SAB BIO Reports Q3 2026 Financial Results and Provides Business Highlights

Indeterminate GlobeNewswire
Medicus Pharma to Present at BIO-Europe 2026
Nov. 5, 2026

Medicus Pharma to Present at BIO-Europe 2026

Indeterminate GlobeNewswire
Dyne Therapeutics Reports Third Quarter 2026 Financial Results and Recent Business Highlights
Nov. 5, 2026

Dyne Therapeutics Reports Third Quarter 2026 Financial Results and Recent Business Highlights

Indeterminate GlobeNewswire
Palvella Therapeutics Reports Third Quarter 2026 Financial Results and Provides Corporate Update
Nov. 5, 2026

Palvella Therapeutics Reports Third Quarter 2026 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire
LifeMD expands access to Lilly’s self-pay GLP-1 medicines, enabling option to dispense and ship directly to patients nationwide
Nov. 5, 2026

LifeMD expands access to Lilly’s self-pay GLP-1 medicines, enabling option to dispense and ship directly to patients nationwide

Indeterminate GlobeNewswire
Newsweek Places KFSH Riyadh in Top 5% of World’s Best Hospitals & Clinics for Medical Tourism 2027
Nov. 5, 2026

Newsweek Places KFSH Riyadh in Top 5% of World’s Best Hospitals & Clinics for Medical Tourism 2027

Indeterminate GlobeNewswire
Addgene Integrates Plasmid and Viral Prep Catalog into Anthropic’s Claude for Life Sciences
Nov. 5, 2026

Addgene Integrates Plasmid and Viral Prep Catalog into Anthropic’s Claude for Life Sciences

Indeterminate GlobeNewswire
Lantheus Welcomes CMS CY27 Final Rule Advancing Access to Diagnostic Radiopharmaceuticals
Nov. 5, 2026

Lantheus Welcomes CMS CY27 Final Rule Advancing Access to Diagnostic Radiopharmaceuticals

Indeterminate GlobeNewswire
Akebia Therapeutics Reports Third Quarter 2026 Financial Results and Business Highlights
Nov. 5, 2026

Akebia Therapeutics Reports Third Quarter 2026 Financial Results and Business Highlights

Indeterminate GlobeNewswire
Herantis Pharma: newly published clinical evidence validates HER-096 Phase 2 study design 
Nov. 5, 2026

Herantis Pharma: newly published clinical evidence validates HER-096 Phase 2 study design 

Indeterminate GlobeNewswire
Nurix Therapeutics to Present New and Updated Data from Ongoing Phase 1a/1b Trial of Bexobrutideg (NX-5948) in Relapsed/Refractory CLL/SLL at the 68th ASH Annual Meeting and Exposition
Nov. 5, 2026

Nurix Therapeutics to Present New and Updated Data from Ongoing Phase 1a/1b Trial of Bexobrutideg (NX-5948) in Relapsed/Refractory CLL/SLL at the 68th ASH Annual Meeting and Exposition

Indeterminate GlobeNewswire
iMDx to Release Third Quarter Results on November 16, 2026
Nov. 5, 2026

iMDx to Release Third Quarter Results on November 16, 2026

Indeterminate GlobeNewswire
Aquestive Therapeutics to Present Data at the 2026 ACAAI Annual Meeting
Nov. 5, 2026

Aquestive Therapeutics to Present Data at the 2026 ACAAI Annual Meeting

Indeterminate GlobeNewswire
Show More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

My Health News Nevada

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.